Abstract
Wounds and wound healing have always been one of the most important subjects that experimental researches were dedicated to. Simvastatin has been used for long as a common lipid lowering agent which was reported to have some pleiotropic effects such as antioxidation, anti-inflammation and immunomodulation. In this study we aimed to determine the effect of simvastatin on wound healing process in laboratory rats by means of stereological and histopathological analyses.
36 male Sprague-Dawley rats (220 ± 20 g) with a 1 cm2 circular full-thickness wound on their back were divided into three groups: SS group that received a gel with 2% concentration of simvastatin; UW group that received no treatment but daily irrigation with normal saline; Base group that was treated with the gel base. Duration of the study was 12 days and at the end, wound closure rate, grade of inflammation, granulation-tissue formation, ulceration, epithelization, fibroblast proliferation, collagen-bundles synthesis, and vascularization were determined.
Outcome of this study revealed that Simvastatin improves the wound healing by its anti-inflammatory and epithelization induction effect as well as statistically significant induction of fibroblast proliferation and collagen bundle synthesis which were reported by our stereological and histopathological investigations.
Results of the present study demonstrated that topical Simvastatin enhances the wound healing process through affecting different aspects of tissue regeneration; however, further researches are needed to find the exact mechanism, advantages and disadvantages of this chemical agent.
Key Words: Simvastatin, Wound healing, Stereology, Reepithelization
Introduction
The wound healing process of skin involves several steps including angiogenesis, reepithelization, fibroblast activation and migration, and endothelial cell proliferation, all along with inflammatory response and oxidative reaction in the damaged tissue (1). The wound repair process begins immediately after injury by the release of different growth factors, cytokines, and etc. In addition, some complications such as disruption of blood vessels, infection and advanced inflammation might be occurred during the repair process (2).
Simvastatin (SS), a HMG-CoA reductase inhibitor, is one of the statin derivatives commonly used as lipid lowering agent. Moreover, different studies demonstrated the various properties of SS such as immunomodulation, anti-inflammation, endothelial function improvement, endothelial nitric oxide synthase inhibition, and anti sepsis effect. Different experimental studies suggested that pleotropic effects of SS are independent of its lipid lowering property. Recent studies also reported possible improving influence of SS in the wound healing process; however, the safety profile of SS was declared excellent especially in local treatments and major side effects were rarely observed and were mostly reversible (3-7).
Since SS presented positive effects on mechanisms that are contributed to wound healing promotion, in this study we aimed to determine the healing effect of this agent on full thickness skin wounds in laboratory rats. There was no report of using unbiased stereological methods (to calculate the rates of wound closure, fibroblast proliferation, collagen synthesis and vascularization) beside histopathological analyses for determining the effects of SS on full thickness skin wound.
Experimental
Preparation of SS gel
SS was obtained from the Pharmacology Department of Shiraz University of Medical Sciences, Shiraz, Iran. In order to facilitate its application, we prepared 2% SS gel by dissolving 2 g SS in 2 cc ethanol (70%), and then transferring the solution into 2% carboxymethylcellulose (CMC) (2 g CMC dissolved in 98 cc distilled water). The base of gel was also supplied by the same method but without SS component.
Animals and Excision of wound model
In an experimental study, 36 male Sprague-Dawley rats (220 ± 20 g) of 2-3 months of age were chosen. General anesthesia was induced by intramuscular injection of mixture of Ketamine (Alfasan™, Woerden, Holland; 0.04 mL/100 g body weight) and Xylazine (Alfasan™, Woerden, Holland; 0.02 mL/10 g body weight). A 1 cm2 circular full-thickness wound was created on the posterior surface of animal’s neck. The rats were randomly divided into three groups. One group was treated with vehicle gel (Base group), a group treated with SS gel (SS group), and the untreated wounded group (UW group) that received no-treatment except cleaning of the wound surface with normal saline every day. After 12 days, the animals were euthanized with ether overdose and full thickness skin biopsies (1 cm×1 cm) were taken from the wound site and were fixed in buffered formaldehyde (pH = 7.2) for histopathological and stereological evaluations.
The study protocol was approved by the Animal Ethics Committee of Shiraz University of Medical Sciences and the animal care was in accordance with their guidelines.
Histopathological study
All the specimens were fixed in formalin, paraffin blocks were provided from the specimens, and 15 µm slides were created from the skins and stained with Hematoxylin-Eosin. All the slides were inspected by a pathologist who was unaware of the groups. Scoring was done for acute and chronic inflammation, ulceration, granulation tissue formation and re-epithelization as presented in Table 1.
Table 1.
Score
|
Criterion | |||
---|---|---|---|---|
Chronic; Dominancy of chronic inflammatory cells in the field | Acute; Dominancy of neutrophils among all cells in the field | Inflammation | ||
Present(1) | Absent(0) | Ulceration | ||
Present(1) | Absent(0) | Granulation tissue | ||
Full, covering 100%of the wound(3) | Moderate; covering > 50% of the wound(2) | Slight; covering < 50% of the wound(1) | Absent(0) | Epithelization |
Wound closure analysis
To determine the wound closure rate, images were captured from the wound surfaces every four days with a digital camera. To calibrate the magnification, a standard ruler was set at the level of the wound in each photograph, and the wound area at each visit was estimated by using a stereology software composed of a point grid (Figure 1) and by using the following formula: Area = ∑ P× a/p; where ∑P was the total points laid on the wound area and a/p, the area surrounded by every four crosses, was considered as the area per point (mm2) (8). Thereafter, the wound closure rate was calculated as:
Wound closure rate (%) = ((area at visit 1 – area at each visit) / area at visit 1) ×100
Tissue preparing and processing
In a systematic random sampling manner (first with a random starting place and others with equal distances), nine pieces of the skin samples were cut and prepared for stereological analysis, each about 1 mm2. The pieces were embedded in a cylindrical paraffin block. The cylindrical blocks were sectioned using orientator methods for generating isotropic uniform random sections (9). The sections with 5 µm and 15 μm thickness were obtained and stained with both Hedenhain's azan and hematoxylin and eosin stains. Microscopic analyses of the dermis were done by using a video-microscopy system made up of a microscope (E-200, Nikon™, Japan) linked to a video camera, and a flat monitor.
Stereological analysis
The volume densities of the collagen bundles (Vv; fraction of the unite volume of the dermis which is occupied by the collagen bundles) were estimated at final magnification of «×450» by using point counting method and the following formula (10, 11):
Vv (collagen/dermis) = P (collagen)/P (dermis)
The P (collagen) was the number of points hitting the profiles of the collagen and P(dermis) was the number of points hitting the dermis (Figure 2).
The length density of the vessels (Lv) and their mean diameter were estimated at final magnification of «×450» and by using the following formula (10, 11):
Lv = 2×ΣQ/ ((a/f) ×Σf)
Where "∑Q" was the total number of vessel profiles counted per rat sample, (a/f) was the area of the counting frame, and "∑f" is the total number of frames counted per animal. Mean diameters of the vessels were calculated by measuring the short axis of a sampled vessel as its diameter (Figure 3). For these purposes, 5 µm sections were employed.
The numerical density (Nv; number of the cells per unit volume of the dermis) of the fibroblasts was estimated by employing 15 μm sections at magnification of ×2000 (Figure 4), the “optical disector” method and the following formula (10, 11):
Nv = ΣQ/ΣA× h
Where "ΣQ" was the number of nuclei coming into focus in the dissector height, "ΣA" was the total area of the unbiased counting frame in all microscopic fields and "h" was the height of disector (5 μm here).
Statistical analysis of the data
Data were collected, analyzed and reported as mean and standard deviation (mean ± SD). Statistical comparisons between stereological outcomes of groups were carried out by using SPSS software (ver. 16.0, Chicago, IL, USA). One-way analysis of variance (ANOVA) followed by Tukey’s post test were used to analyze the data. P ≤ 0.05 was considered as statistically significant.
Results
Pathological study results
According to pathological comments, ulceration, acute inflammation, granulation tissue formation, and slight epithelization (score 1) were the dominant presentations in the UW group. In base group, acute inflammation was observed in the rats as the governing type of inflammation; ulceration, granulation tissue formation and slight epithelization (score 1) were also dominant in base group. Group SS had no sign of inflammation at the day 12 except one of the animals with acute inflammation; full epithelization (score 3) was seen in the rats except one of them with score 2 epithelization.
Wound closure rate
The initial area of the wounds was 104.37 ± 4.11 mm2 with insignificant difference among the experimental groups. The rate of wound closure in SS group was significantly higher in comparison with the UW and base groups (P < 0.05) (Figure 5). The base group was shown to have inconsequentially slower closure rate comparing to the UW group.
Fibroblast population
Numerical density of the fibroblasts (Nv) in the dermis of SS group was reported to be 103% higher than UW (P > 0.001) and 95% higher than the base group (P > 0.001) (Table 2).
Table 2.
Vessels
|
Collagen
|
Fibroblasts
|
Groups | ||
---|---|---|---|---|---|
Mean Diameter | Length density | % Volume density | % Volume density | Numerical density | |
2.20(0.44) | 20.21(8.10) | 3.25% (2.75%) | 54 %( 4 %) | 17.33(8.28) | UW |
3.45(1.23)* | 16.57(3.89) | 4.09% (1.75%) | 71% (6%)* | 35.23(6.90)* | SS |
1.22(0.28) | 17.16(7.25) | 2.40% (2.79%) | 49% (5%) | 18.02(6.65) | Base |
* p < 0.05, SS group vs. UW group and Base group
Volume density of the collagen bundles
The volume densities of the collagen bundles were significantly higher in SS group comparing to those of the UW and base groups (P < 0.001) (Table 2).
Volume density, Length density and diameter of the vessels
The mean of volume densities of vessels in SS group were insignificantly higher than UW and base groups by 26% (P = 0.79) and 52% (P = 0.36) respectively. Statistical analysis of length densities of the vessels revealed lower mean values in SS group (P = 0.79) and base group (P = 0.83) comparing to the UW group (Table 2).
Comparing the means of vessel diameters demonstrated that this parameter was higher than the base group by 57% (P = 0.01) in UW group and by 182% (P = 0.005) in SS group (Table 2).
Results and Discussion
Cutaneous wound healing is a complex process involving inflammation, fibroblast proliferation, angiogenesis, collagen bundle formation, and finally tissue remodeling (1). The results of different studies demonstrated the wound healing properties of various exogenous substances and also instrumental therapies such as laser therapy which were in most cases beneficial on the healing process examined by experimental and clinical methods (12).
Statins, particularly SS, are commonly used clinically for treatment of hypercholesterolemia. Moreover, various studies indicated different pleiotropic properties of statins such as anti-inflammatory, endothelium protective, anti-thrombotic and anti coagulant, immunomodulatory, and antioxidant activity (-, 13, 14). Previous experiments revealed that among different statin derivatives, SS was determined as one of the best anti-inflammatory agents (15, 16). In a study by Rego et al. it was shown that topical administration of SS on open skin wounds not only had anti-inflammatory effect, but also reduced bacterial infection of the wound site (17). Results of our study have suggested the anti-inflammatory effect of topical SS gel as well. Some studies exhibited that SS administration improved endothelial cell proliferation as well as neovascularization (18), which was also supported by outcomes of the present study. Cakmak et al. (2009) had shown that oral administration of SS improved intestinal wound healing in rats; they also mentioned the anti-oxidative and immunomodulatory impacts of this agent in their investigation (19).
In the present study, we showed that topical administration of 2% SS gel improved the rate of wound closure in laboratory rats. Pathological analyses also confirmed the anti-inflammatory effect of the agent as well as positive influence on granulation tissue formation and re-epithelization which hastened the healing process. Based on stereological outcomes, SS augmented the proliferation of fibroblasts, collagen bundles and also vessel formation which all accelerate the healing course; however, stereological parameters suggesting the vascularization induction influence were not statistically noticeable in contrast to other experimental groups.
To come into conclusion, SS revealed positive effect on the wound healing process considering pathological and stereological outcomes that were used in this experimental study; however, further investigations, particularly clinical studies, are needed to approve this agent as a treatment in skin injuries and wound healing and to determine the exact mechanisms involved.
Acknowledgments
This study was supported by Shiraz University of medical sciences. Authors would like to thank Dr. Vahedi and Mr. Omid Koohi Hosseinabadi for their generous contribution in this experimental study.
References
- 1.Martin P. Wound healing-aiming for perfect skin regeneration. Sci. 1997; 276:75–81. doi: 10.1126/science.276.5309.75. [DOI] [PubMed] [Google Scholar]
- 2.Clark RAF. Regulation of fibroplasia in cutaneous wound repair. Am J. Med. Sci. 1993;306:42–8. doi: 10.1097/00000441-199307000-00011. [DOI] [PubMed] [Google Scholar]
- 3.Kwak B, Mulhaupt F, Myit S. Statins as a newly recognized type of immunomodulator. Nat Med. . 2000;6:1399–1402. doi: 10.1038/82219. [DOI] [PubMed] [Google Scholar]
- 4.Pruefer D, Makowski J, Schnell M. Simvastatin inhibits inflammatory properties of Staphylococcus aureus alpha toxin. Circulation. 2003;106:2104–2110. doi: 10.1161/01.cir.0000034048.38910.91. [DOI] [PubMed] [Google Scholar]
- 5.Laufs U, Liao JK. Post-transcriptional regulation of endothelial nitric oxide synthase mRNA stability by Rho GTPase. J Biol. Chem. . 1998;273:24266–24271. doi: 10.1074/jbc.273.37.24266. [DOI] [PubMed] [Google Scholar]
- 6.Merx MW, Liehn EA, Janssens U, Lütticken R, Schrader J, Hanrath P, Weber C. HMG-CoA reductase inhibitor simvastatin profoundly improves survival in a murine model of sepsis. Circulation. 2004;109 doi: 10.1161/01.CIR.0000129774.09737.5B. [DOI] [PubMed] [Google Scholar]
- 7.Singh H, Philip B, Pathak K. Preparation, Characterization and Pharmacodynamic Evaluation of Fused Dispersions of Simvastatin using PEO-PPO Block Copolymer. Iran. 2012;11:433–445. [PMC free article] [PubMed] [Google Scholar]
- 8.Ashkani-Esfahani S, Imanieh MH, Khoshneviszadeh M, Meshksar A, Noorafshan A, Geramizadeh B, Ebrahimi S, Handjani F, Tanideh N. The Healing Effect of Arnebia Euchroma in Second Degree Burn Wounds in Rat as an Animal Model. Iran Red Crescent Med. J. . 2012;14:70–74. [PMC free article] [PubMed] [Google Scholar]
- 9.Ashkani-Esfahani S, Emami Y, Esmaeilzadeh E, Bagheri F, Namazi MR. Glucosamine Enhances Tissue Regeneration in the Process of Wound Healing in Rats as Animal Model: A Stereological Study. J Cytol. Histol. . 2012;3:150. [Google Scholar]
- 10.Ashkani-Esfahani S, Imanieh MH, Meshksar A, Khoshneviszadeh M, Noorafshan A, Geramizadeh B, Ebrahimi S, Handjani Fa, Nadimi E. Enhancement of Fibroblast Proliferation, Vascularization and Collagen Synthesis in the Healing Process of Third-Degree Burn Wounds by Topical Arnebia euchroma, a Herbal Medicine. Galen Med J. . 2012;1:53–59. [Google Scholar]
- 11.Mühlfeld C, Nyengaard J, Mayhew T. A review of state of the-art stereology for better quantitative 3D morphology in cardiac research. Cardiovasc Pathol. 2012;19:65–82. doi: 10.1016/j.carpath.2008.10.015. [DOI] [PubMed] [Google Scholar]
- 12.Peplow PV, Chung T-Y, Baxter GD. Laser Photobiomodulation of Wound Healing: A Review of Experimental Studies in Mouse and Rat Animal Models. Photomedicine and Laser Surger. 2010;28:291–325. doi: 10.1089/pho.2008.2446. [DOI] [PubMed] [Google Scholar]
- 13.Giusti-Paiva A, Martinez MR, Felix JV, da-Rocha MJ, Carnio EC, Elias LL, Antunes-Rodrigues J. Simvastatin decreases nitric oxide overproduction and reverts the impaired vascular responsiveness induced by endotoxic shock in rats. Shock. 2004;21:271–275. doi: 10.1097/10.shk.0000115756.74059.ce. [DOI] [PubMed] [Google Scholar]
- 14.Wiesbauer F, Kaun C, Zorn G, Maurer G, Huber K, Wojta J. HMG CoA reductase inihibitors affect the fibrinolytic system of human vascular cells in vitro: a comparative study using different statins. Br J. Pharmacol. 2002;135:284–292. doi: 10.1038/sj.bjp.0704454. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Wiklund O, Mattsson-hultén L, Hurt-camejo E, Oscarsson J. Effects of simvastatin and atorvastatin on inflammation markers in plasma. J Int. Med. . 2002;251:338–347. doi: 10.1046/j.1365-2796.2002.00966.x. [DOI] [PubMed] [Google Scholar]
- 16.Ebrahimi S, Ashkani-Esfahani S, Poormahmudi A. Investigating the efficacy of Zizyphus jujuba on neonatal jaundice. Iran. j. pediatrics. 2011;21 [PMC free article] [PubMed] [Google Scholar]
- 17.Rego ACMd, Filho IA, Damasceno BPGL, Egito EST, Silveira IAd, Brandão-Neto J, Medeiros AC. Simvastatin improves the healing of infected skin wounds of rats. Acta Cirúrgica Brasileira. 2007;22:57–63. doi: 10.1590/s0102-86502007000700012. [DOI] [PubMed] [Google Scholar]
- 18.Park KW, Hwang KK, Cho HJ, Hur J, Jang HM, Yoon CH, Kang HJ, Oh BH, Park YB, Kim HS. Simvastatin enhances endothelial differentiation of peripheral blood mononuclear cells in hypercholesterolemic patients and induces pro-angiogenic cytokine IL-8 secretion from monocytes. Clin Chim. Acta. . 2008;388:156–66. doi: 10.1016/j.cca.2007.10.027. [DOI] [PubMed] [Google Scholar]
- 19.Cakmak GK, Irkorucu O, Ucan BH, Emre AU, Bahadir B, Demirtas C, Tascilar O, Karakaya K, Acikgoz S, Kertis G, Ankarali H, Pasaoglu H, Comert M. Simvastatin Improves Wound Strength after Intestinal Anastomosis in the Rat. J Gastrointest Surg. . 2009;13:1707–1716. doi: 10.1007/s11605-009-0951-2. [DOI] [PubMed] [Google Scholar]